Skip to main content
MIRMirion Technologies, Inc.Sell5.7·$18.67
SellModerate Confidence
Investment thesis

Mirion Technologies combines industry-leading 28% revenue growth and exceptional 271% free cash flow conversion with a confirmed technical downtrend and 19% short interest — the gap between fundamental quality and current price is wide, but near-term catalysts are needed to close it.

Thesis pillars

  • Analyst Upside Risk Reward↓Deteriorating
  • Exceptional Cash Conversion↓Deteriorating
  • Industry Leading Revenue Growth↑Improving
  • +2 more pillars — see the Why tab for full reasoning

Pillars as of Jul 3, 2026, based on the 10-K filed Feb 19, 2026

Full reasoning →

Open full analysis

Mirion Technologies, Inc. (MIR) Stock Analysis

Momentum Cont setup

SellGrowthShortModerate Confidence

Industrials · Specialty Industrial Machinery

Sell if holding. At $18.67, A.R:R 0.7:1 is below the 1.5:1 minimum. Reward from here is too thin for a buy — the engine flags exit. Additional concerns: Thin upside margin: 9.7%; Concentration risk — Supplier: sole or limited source suppliers.

Mirion Technologies provides radiation detection, measurement, and monitoring products, software, and services across two segments — Nuclear & Safety and Medical — operating in 12 countries. The company sells to nuclear power plants (present in over 98% globally), cancer centers... Read more

$18.67+9.7% A.UpsideScore 5.7/10#24 of 56 Specialty Industrial Machinery
QualityF-score9 / 9FCF yield—
Stop $17.36Analyst target $20.48(−13% haircut)A.R:R 0.7:1
Analyst consensus$23.55+26.1%11 analysts
$20.48Analyst target
$18.67price
$23.55mean
$29

Sell if holding. At $18.67, A.R:R 0.7:1 is below the 1.5:1 minimum. Reward from here is too thin for a buy — the engine flags exit. Additional concerns: Thin upside margin: 9.7%; Concentration risk — Supplier: sole or limited source suppliers. Chart setup: Trend continuation, RSI 65, MACD bullish. Score 5.7/10, moderate confidence.

Passes 5/8 gates (positive momentum, clean insider activity, earnings proximity 102d clear, semi cycle peak clear, materials cycle peak clear). Fails on favorable risk/reward ratio. Suitability: aggressive.

10-K grounded · weekly refresh

About Mirion Technologies, Inc.

About Mirion Technologies, Inc.

Mirion Technologies' Nuclear & Safety and Medical segments drew approximately 48% of fiscal 2025 net sales from customers in the United States and Canada, 33% from Europe, and 17% from Asia Pacific, with the company's radiation monitoring solutions installed in more than 98% of nuclear power plants globally. Mirion closed two acquisitions in 2025: Certrec in July (regulatory compliance software for the nuclear sector) and Paragon Energy Solutions in December (obsolescence and parts availability for NPPs), both integrated into Nuclear & Safety.

The Nuclear & Safety segment serves the full lifecycle of nuclear power plants — construction, operation, decommissioning — as well as laboratories, defense forces including 23 of 32 NATO militaries, and industrial end markets. Over 80% of Nuclear & Safety's power end-market revenue comes from the installed base of existing NPPs, driving replacement and service cycles tied to the 40- to 100-year operating life of a nuclear plant. The Medical segment serves cancer centers with radiation therapy quality assurance systems and nuclear medicine tools, and provides dosimetry services badging over one million wearers globally. Service revenue represented 25.4% of consolidated revenue in fiscal 2025, providing a recurring revenue base. The company relies on third-party suppliers including sole or limited-source providers for certain components, exposing it to supply disruption risk; sales cycles for NPP new-build projects range from 12 to 60 or more months.

Show full overview

A substantial portion of Mirion's U.S. revenue comes from contracts with U.S. governmental customers or their contractors — including the Departments of Energy, State, Defense, and Homeland Security — making government budget cycles and procurement timelines a key driver of order flow. Escalation of U.S. or EU sanctions targeting Russian state-owned enterprises involved in nuclear construction could further complicate revenue recognition in the nuclear segment; the company has already experienced delayed contract payments and export license requirements in Russia and will continue to navigate a complex sanctions regime.

See also: Industrials · Specialty Industrial Machinery

From Mirion Technologies, Inc.'s most recent 10-K filing, extracted June 11, 2026.

news + 30-day 8-K events · 5-min refresh

Recent developments

updated 2026-10-30
TrendMatrix Research · upcoming catalyst calendar

Upcoming dated catalysts

Tue, Feb 9, 2027102d to earnings· next earnings call

Thesis

Rewards
Strong growth profile
Positive momentum
Risks
Concentration risk — Supplier: sole or limited source suppliers
Thin upside margin: 9.7%
V7 low-quality RISK_OFF penalty: -0.5 (Q=4.3)

Key Metrics

P/E (TTM)169.7
P/E (Fwd)27.9
Mkt Cap$4.6B
EV/EBITDA—
Profit Mgn2.7%
ROE1.6%
Rev Growth24.5%
Beta1.10
DividendNone
Rating analysts15

Quality Signals

Piotroski F9/9MoatNarrow

Options Flow

P/C0.44bullish
IV64%elevated

Concentration Risks(10-K Item 1A)

  • MEDIUMGeographicUnited States and Canada48%
    10-K Item 1: 'Sales to customers inside the United States and Canada accounted for approximately 48% of total revenue for fiscal 2025'
  • MEDIUMGeographicEurope33%
    10-K Item 1: 'an additional 33% and 17% of total revenue accounted for by sales to customers in Europe and Asia Pacific respectively'
  • LOWGeographicAsia Pacific17%
    10-K Item 1: 'an additional 33% and 17% of total revenue accounted for by sales to customers in Europe and Asia Pacific respectively'
  • HIGHSuppliersole or limited source suppliers
    10-K Item 1A: 'We rely on third party suppliers for our manufacturing operations including from sole or limited source suppliers'
  • MEDIUMCustomerU.S. governmental customers
    10-K Item 1A: 'We derive a substantial portion of our U.S. revenue from contracts with U.S. governmental customers or their contractors'

Material Events(8-K, last 90d)

  • 2026-04-13Item 5.02LOW
    April 9, 2026: Board approved a special one-time grant of 2,500,000 performance vesting stock options (7-year term) to CEO Thomas Logan, vesting based on continued service and total shareholder return relative to the Russell 2000 Index over 3- and 4-year performance periods.
    SEC filing →

Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results. How we score · Editorial policy

Show full disclosure ▾

About TrendMatrix. TrendMatrix is a publisher of general securities research and market commentary. We publish on a regular schedule. All content is the same for every subscriber in a tier — we do not provide personalized investment advice and we do not take into account any individual subscriber's financial situation, investment objectives, risk tolerance, tax situation, or holdings.

Not investment advice. TrendMatrix is not a registered investment adviser. Our content is for informational and educational purposes only. Consult your own licensed investment adviser, broker, or tax professional before making any investment decision.

Conflicts and positions. People who build TrendMatrix, or entities they control, may hold positions, long or short, in securities it covers, and may trade them at any time. Positions are not disclosed individually. Verdicts are generated by an automated model applied by the same rules to every covered stock, and are not adjusted for any position held by the people who build TrendMatrix. We do not accept payment from issuers for coverage.

No paid promotion. TrendMatrix does not accept payment from any issuer, broker, or third party in exchange for coverage of any security.

No fiduciary duty. No fiduciary, advisory, or agency relationship is created between you and TrendMatrix by reading our content or subscribing to our service.

Performance. Past performance is not indicative of future results. Performance figures reflect the published model only and do not reflect any individual subscriber's actual results.

Methodology · Editorial policy & full disclaimer

Rating Breakdown

2 floor-breakers·1 ceiling hit

Technicals below the gate floor. Component breakdown shows what dragged the score down.static

Bollinger
0.0
Support Resistance
0.2
52w Position
2.3

Ranks in the bottom of its industry peers on the composite signal. Better names in the same sector exist.static

Value Rank
0.2
Quality Rank
1.1
Growth Rank
8.0
GatesA.R:R 0.7 < 1.5@spotDeath cross (50MA < 200MA)Executive change: officer departure/appointmentMomentum 8.3>=5.5Insider activity: OKEARNINGS PROXIMITY 102d clearSEMI CYCLE PEAK CLEARMATERIALS CYCLE PEAK CLEARMomentum ContSuitability: Aggressive
RSI
65 · Neutral
↑ 20D MA↑ 50D MA↑ 200D MADEATH CROSSSupport $14.28Resistance $18.77

Price Targets

$17
$20
A.Upside+9.7%
A.R:R0.7:1

Position Sizing

ConvictionNone
Suggested %0%
Max %0%
RegimeRisk-Off

Risk Alerts

! asymmetry at 0.7 (below the engine's 1.5 threshold)@spot

Earnings

B
B
M
M
2/4 beats
Next Earnings2027-02-09 (102d)

Verdict History

reverse chrono — latest first
Loading history...
Verdicts are recorded on every nightly pipeline run. Rows capture transitions (verdict flips, score deltas ≥0.3, entry/TP/SL changes). Rows with a ▶ can be expanded to see the change reason. Aggregate cohort performance is tracked in the recommendation ledger.
Frequently Asked Questions
Is MIR stock a buy right now?

Sell if holding. At $18.67, A.R:R 0.7:1 is below the 1.5:1 minimum. Reward from here is too thin for a buy — the engine flags exit. Additional concerns: Thin upside margin: 9.7%; Concentration risk — Supplier: sole or limited source suppliers. Chart setup: Trend continuation, RSI 65, MACD bullish. Prior stop was $17.36. Score 5.7/10, moderate confidence.

What is the MIR stock price target?

Analyst target: $20.48 (+9.7% upside). Prior stop was $17.36. Stop-loss: $17.36.

What are the risks of investing in MIR?

Concentration risk — Supplier: sole or limited source suppliers; Thin upside margin: 9.7%; V7 low-quality RISK_OFF penalty: -0.5 (Q=4.3).

Is MIR overvalued or undervalued?

Mirion Technologies, Inc. trades at a P/E of 169.7 (forward 27.9). TrendMatrix value score: 4.1/10. Verdict: Sell.

What do analysts say about MIR?

15 analysts cover MIR with a consensus score of 4.1/5. Average price target: $24.

What does Mirion Technologies, Inc. do?Mirion Technologies provides radiation detection, measurement, and monitoring products, software, and services across...

Mirion Technologies provides radiation detection, measurement, and monitoring products, software, and services across two segments — Nuclear & Safety and Medical — operating in 12 countries. The company sells to nuclear power plants (present in over 98% globally), cancer centers (over 80% worldwide), and 23 of 32 NATO militaries, with service revenue at approximately 25% of consolidated revenue in fiscal 2025.

Related stocks: AMSC (American Superconductor Corpora) · EPAC (Enerpac Tool Group Corp.) · XE (X-Energy, Inc.) · GTES (Gates Industrial Corporation Lt) · HLIO (Helios Technologies, Inc.)
Home › Stocks › MIR

Latest news

Latest News

MSN184d agoEarnings
Yahoo Finance184d agoEarnings
Cổng thông tin điện tử Tỉnh Sơn La191d ago
아시아경제191d ago
Yahoo Finance94d agoEarnings
Yahoo Finance94d ago
StockStory94d ago
TradingView94d ago
Yahoo Finance94d ago
Marketscreener.com94d agoEarnings
TradingKey94d ago
Quiver Quantitative185d agoEarnings
StockStory185d ago
TradingView185d ago
FinancialContent185d ago
Marketscreener.com185d agoEarnings
MarketBeat185d ago
Marketscreener.com185d agoEarnings
Yahoo Finance3d agoEarnings
Yahoo Finance3d agoEarnings
Loading more...